Oral Cancer
Squamous Cell Carcinoma of the Tongue
Male, 72 years
Patient Internal ID: 1521377115
ICD-10 code
C02.8 Overlapping Lesion of Tongue
Diagnosis (Incl. Metastases/Stage) and Year
April 2023
HPV associated Squamous Cell Carcinoma of the Tongue, Stage 4. Focal Lymph Nodes Invasion, suspected growth to Oesophagus. Ki67 >80%.
Previous Treatment
Radiotherapy, Chemotherapy (Docetaxel, Cisplatin, Capecitabine
Prognosis and Survival Expectation
The prognosis remains poor, studies revealed a 5-year survival rate of 50.3% for Oral Cancer patients, with a survival rate of 38% for Tongue Cancer patients. The average survival time for Tongue Cancers after the non-curative treatment decision, was 3.7 months.
Treatment Provided
Autologous DCV (4 doses) over a period of 2 months. Additionally, the patient received Mistletoe Therapy.
Patient Survival/Condition and Year
Date of Review: 01/02/2024
The patient has survived for 10 months since the diagnosis. The Oral Cancer is non-operative. The latest PET-CT scan showed reduction of tumor and complete response to the treatment. It can be concluded that the addition of Immunotherapy has reduced the size of tumor and extended patient survival by an estimate of around 6 months so far.
